Intimation of Closure of Trading Window for the Quarter and Half year Ending 30th September, 2026

lBL‘ Indrayani Biotech Inclusive Growth Date: 29.09.2026 BSE Limited, Dept. of Corporate Services, Floor 25, P] Towers, Dalal Street, Mumbai- 400001. rip Code: 52644 Dear Madam/Sir, Sub: Closure of Trading Window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. We wish to inform you that, in terms of the Company’s Code of Internal Procedures and Conduct for Prohibition of Insider Trading pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for trading and dealing in securities of t rh ee m ac io nm cp la on sy ed b fy r oth me O cDi tr oe bc et ro r 0s 1, , D 2e 0s 2i 6g ,n ta it lle td h ep e er xs po in rs y oa fn d 4 8t h he oi ur r si m am fe ted ri ta ht ee dr ee cl la at ri av tes i ow ni l ol f Unaudited Financial Statements of the Company for the Quarter and Half year ending September 30, 2026. Pursuant to the SEBI circular SEBI/HO/ISD/lSD-PoD—Z/P/CIR/2023/124 dated July 19, 2023, the Company has also updated the Trading Window closure for the quarter and Half year ending September 30, 2026 along with the relevant details in the National S Pe ec ru sr oi nti se bs y D fe rp eo es zi int go r Py A NL i am ti t se ed cu r( iN tS y D lL e) ve lp io nr t ca ol m pf lo ir anr ces et r wi ic tt hi n tg h et r sa ad ii dn cg i rb cuy l arD .e s Ti hg en a dt ae td e of Board Meeting for declaration of the unaudited financial Statements of the Company for the quarter and Half year ending September 30, 2026 will be intimated in due course. We request you to kindly take this on record. Yours Faithfully For and Behalf of Indrayani Biotech Limited Swaminathan Govindarajan Whole-time Director DIN:02481041